[{"id":"deedd814-45d7-45c3-b510-5266ccf71ee4","acronym":"","url":"https://clinicaltrials.gov/study/NCT03196414","created_at":"2021-01-18T15:45:41.018Z","updated_at":"2024-07-02T16:36:59.951Z","phase":"Phase 1/2","brief_title":"Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma","source_id_and_acronym":"NCT03196414","lead_sponsor":"The First Affiliated Hospital of Soochow University","biomarkers":" SDC1","pipe":" | ","alterations":" SDC1 positive","tags":["SDC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SDC1 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CART-138 • CART-138/BCMA/19/more"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 09/01/2016","start_date":" 09/01/2016","primary_txt":" Primary completion: 09/01/2026","primary_completion_date":" 09/01/2026","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2019-05-02"}]